Evidence map›Paper›PMID 34025934›Full record

ArticleComputational and structural biotechnology journal2021

Computational modeling and bioinformatic analyses of functional mutations in drug target genes in

Pooja Singh, Salma Jamal, Faraz Ahmed, Najumu Saqib, Seema Mehra, Waseem Ali, Deodutta Roy, Nasreen Z Ehtesham, Seyed E Hasnain

Open access · goldAbstract read
In one paragraph

Article in Computational and structural biotechnology journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Drug resistance mechanisms inFrontiers in pharmacology · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. A simplified pyrazinamidase test forJournal of clinical microbiology · 2024
    Article
  7. Genome and transcriptomic analysis of the adaptation ofComputational and structural biotechnology journal · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Pooja SinghJamia Hamdard Institute of Molecular Medicine, Jamia Hamdard, New Delhi 110062, India.
Salma JamalJamia Hamdard Institute of Molecular Medicine, Jamia Hamdard, New Delhi 110062, India.
Faraz AhmedJamia Hamdard Institute of Molecular Medicine, Jamia Hamdard, New Delhi 110062, India.
Najumu SaqibJamia Hamdard Institute of Molecular Medicine, Jamia Hamdard, New Delhi 110062, India.
Seema MehraJamia Hamdard Institute of Molecular Medicine, Jamia Hamdard, New Delhi 110062, India.
Waseem AliJamia Hamdard Institute of Molecular Medicine, Jamia Hamdard, New Delhi 110062, India.
Deodutta RoyDepartment of Environmental and Occupational Health, Florida International University, Miami 33029, USA.
Nasreen Z EhteshamICMR-National Institute of Pathology, Safdarjung Hospital Campus, New Delhi, India.
Seyed E HasnainDepartment of Life Sciences, School of Basic Sciences and Research, Sharda University, Greater Noida 201301, India.
Jamia Hamdard · INFlorida International University · USIndian Institute of Technology Delhi · INSafdarjang Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tuberculosis (TB) continues to be the leading cause of deaths due to its persistent drug resistance and the consequent ineffectiveness of anti-TB treatment. Recent years witnessed huge amount of sequencing data, revealing mutations responsible for drug resistance. However, the lack of an up-to-date repository remains a barrier towards utilization of these data and identifying major mutations-associated with resistance. Amongst all mutations, non-synonymous mutations alter the amino acid sequence of a protein and have a much greater effect on pathogenicity. Hence, this type of gene mutation is of prime interest of the present study. The purpose of this study is to develop an updated database comprising almost all reported substitutions within the

Indexed as

Genome sequencingMDRMycoTRAP-DBSecondary mutationsSNPsTuberculosis

Identifiers

PMID34025934
PMCPMC8113780
OpenAlexW3154260147

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.